JP2007507511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007507511A5 JP2007507511A5 JP2006534029A JP2006534029A JP2007507511A5 JP 2007507511 A5 JP2007507511 A5 JP 2007507511A5 JP 2006534029 A JP2006534029 A JP 2006534029A JP 2006534029 A JP2006534029 A JP 2006534029A JP 2007507511 A5 JP2007507511 A5 JP 2007507511A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- phenyl
- benzimidazole
- propoxy
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000001424 substituent group Chemical group 0.000 claims 12
- 229910052799 carbon Inorganic materials 0.000 claims 11
- 125000003545 alkoxy group Chemical group 0.000 claims 9
- 125000004122 cyclic group Chemical group 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 8
- -1 -OCH 2 Ph Chemical group 0.000 claims 6
- 125000005842 heteroatom Chemical group 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 125000004008 6 membered carbocyclic group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 3
- 125000001054 5 membered carbocyclic group Chemical group 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- PMSKRMBSAZKNAO-UHFFFAOYSA-N 6-tert-butyl-2-[2-methyl-4-[3-(2-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound CC1CNCCN1CCCOC(C=C1C)=CC=C1C1=NC2=CC(C(C)(C)C)=CC=C2N1 PMSKRMBSAZKNAO-UHFFFAOYSA-N 0.000 claims 2
- HOGIQAJOASEATP-UHFFFAOYSA-N 6-tert-butyl-2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)C=C1Cl HOGIQAJOASEATP-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 150000001721 carbon Chemical group 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- WFYUITPFJSNEQQ-UHFFFAOYSA-N 1-[2-(5-fluoro-4-methyl-1h-benzimidazol-2-yl)-5-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-n,n-dimethylmethanamine Chemical compound C=1C=C(C=2NC3=CC=C(F)C(C)=C3N=2)C(CN(C)C)=CC=1OCCCC1CCN(C)CC1 WFYUITPFJSNEQQ-UHFFFAOYSA-N 0.000 claims 1
- JMGPTTNPUMSBTQ-UHFFFAOYSA-N 1-[2-(6-chloro-4-methyl-1h-benzimidazol-2-yl)-5-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-n,n-dimethylmethanamine Chemical compound C=1C=C(C=2NC3=CC(Cl)=CC(C)=C3N=2)C(CN(C)C)=CC=1OCCCC1CCN(C)CC1 JMGPTTNPUMSBTQ-UHFFFAOYSA-N 0.000 claims 1
- AADBANJKFIORNE-UHFFFAOYSA-N 1-[3-[4-(6-tert-butyl-1h-benzimidazol-2-yl)-2-chlorophenoxy]propyl]-n,n-dimethylpyrrolidin-3-amine Chemical compound C1C(N(C)C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)C=C1Cl AADBANJKFIORNE-UHFFFAOYSA-N 0.000 claims 1
- QSSIZKWOJDCWML-UHFFFAOYSA-N 2-[2-chloro-4-[2-methyl-3-(4-methylpiperazin-1-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C=1C=C(C=2NC3=CC=CC(C)=C3N=2)C(Cl)=CC=1OCC(C)CN1CCN(C)CC1 QSSIZKWOJDCWML-UHFFFAOYSA-N 0.000 claims 1
- CCHJDYXWLQLTHD-UHFFFAOYSA-N 2-[2-chloro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-3h-benzo[e]benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1Cl)=CC=C1C(N1)=NC2=C1C=CC1=CC=CC=C21 CCHJDYXWLQLTHD-UHFFFAOYSA-N 0.000 claims 1
- ZBKOPZVHMTXXQH-UHFFFAOYSA-N 2-[2-chloro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-4,5-dimethyl-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C(C)=CC=C2N1 ZBKOPZVHMTXXQH-UHFFFAOYSA-N 0.000 claims 1
- BYEFGIKEWXKOAC-UHFFFAOYSA-N 2-[2-chloro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-4,6-dimethyl-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=C(C)C=C2N1 BYEFGIKEWXKOAC-UHFFFAOYSA-N 0.000 claims 1
- YPWPMKJVTQONQH-UHFFFAOYSA-N 2-[2-chloro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=CC=C2N1 YPWPMKJVTQONQH-UHFFFAOYSA-N 0.000 claims 1
- RPIXQBZODSVPPC-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methyl-1,4-diazepan-1-yl)propoxy]phenyl]-4,5-dimethyl-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C(C)=CC=C2N1 RPIXQBZODSVPPC-UHFFFAOYSA-N 0.000 claims 1
- JMQRDCNEFGNPAL-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methyl-1,4-diazepan-1-yl)propoxy]phenyl]-4,6-dimethyl-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=C(C)C=C2N1 JMQRDCNEFGNPAL-UHFFFAOYSA-N 0.000 claims 1
- WMGUYQXCPREFOF-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methyl-1,4-diazepan-1-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=CC=C2N1 WMGUYQXCPREFOF-UHFFFAOYSA-N 0.000 claims 1
- PBYAQWILYFZYHC-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC=CC=C2N1 PBYAQWILYFZYHC-UHFFFAOYSA-N 0.000 claims 1
- SKQKGGHCXLOMFJ-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-3h-benzo[e]benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C(N1)=NC2=C1C=CC1=CC=CC=C21 SKQKGGHCXLOMFJ-UHFFFAOYSA-N 0.000 claims 1
- FKLHKZSFHAZKBD-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-4,5-dimethyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C(C)=CC=C2N1 FKLHKZSFHAZKBD-UHFFFAOYSA-N 0.000 claims 1
- SIDSFFAOACXBRD-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-4,6-dimethyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=C(C)C=C2N1 SIDSFFAOACXBRD-UHFFFAOYSA-N 0.000 claims 1
- DIFIANIFCWCWIA-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=CC=C2N1 DIFIANIFCWCWIA-UHFFFAOYSA-N 0.000 claims 1
- NPYCKTMZMUAVJW-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-5-fluoro-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C(F)=CC=C2N1 NPYCKTMZMUAVJW-UHFFFAOYSA-N 0.000 claims 1
- NYNGHPOORNFKGZ-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-(trifluoromethoxy)-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC(OC(F)(F)F)=CC=C2N1 NYNGHPOORNFKGZ-UHFFFAOYSA-N 0.000 claims 1
- KGTCKJNHHCXYEZ-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-(trifluoromethyl)-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC(C(F)(F)F)=CC=C2N1 KGTCKJNHHCXYEZ-UHFFFAOYSA-N 0.000 claims 1
- FEMHOUCJHZSJJV-UHFFFAOYSA-N 2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC(C)=CC=C2N1 FEMHOUCJHZSJJV-UHFFFAOYSA-N 0.000 claims 1
- KHADFEDGWBHJSK-UHFFFAOYSA-N 2-[2-methoxy-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-(trifluoromethyl)-1h-benzimidazole Chemical compound C=1C=C(C=2NC3=CC=C(C=C3N=2)C(F)(F)F)C(OC)=CC=1OCCCN1CCN(C)CC1 KHADFEDGWBHJSK-UHFFFAOYSA-N 0.000 claims 1
- KBYGQHKVXVNPHA-UHFFFAOYSA-N 2-[3-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=CC(C=2NC3=CC=CC=C3N=2)=C1 KBYGQHKVXVNPHA-UHFFFAOYSA-N 0.000 claims 1
- BHXFOAZKCRAEEO-UHFFFAOYSA-N 2-[3-chloro-4-[3-(4-methyl-1,4-diazepan-1-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCOC1=CC=C(C=2NC3=CC=CC(C)=C3N=2)C=C1Cl BHXFOAZKCRAEEO-UHFFFAOYSA-N 0.000 claims 1
- UMNDIUWKZLKSRC-UHFFFAOYSA-N 2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=CC=C3N=2)C=C1Cl UMNDIUWKZLKSRC-UHFFFAOYSA-N 0.000 claims 1
- ZJSRVCKWBKNRCM-UHFFFAOYSA-N 2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-(trifluoromethyl)-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C=C3N=2)C(F)(F)F)C=C1Cl ZJSRVCKWBKNRCM-UHFFFAOYSA-N 0.000 claims 1
- PVHPABJTUPOEHL-UHFFFAOYSA-N 2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-methoxy-1h-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1C(C=C1Cl)=CC=C1OCCCN1CCN(C)CC1 PVHPABJTUPOEHL-UHFFFAOYSA-N 0.000 claims 1
- QMGSOQRJRHUXGG-UHFFFAOYSA-N 2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C)C=C3N=2)C=C1Cl QMGSOQRJRHUXGG-UHFFFAOYSA-N 0.000 claims 1
- GYWXPRKRKOTZFC-UHFFFAOYSA-N 2-[3-fluoro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=CC=C3N=2)C=C1F GYWXPRKRKOTZFC-UHFFFAOYSA-N 0.000 claims 1
- PAHZWMXYPGJECS-UHFFFAOYSA-N 2-[3-fluoro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=CC(C)=C3N=2)C=C1F PAHZWMXYPGJECS-UHFFFAOYSA-N 0.000 claims 1
- FOWBFPKYEHZJDX-UHFFFAOYSA-N 2-[3-fluoro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C)C=C3N=2)C=C1F FOWBFPKYEHZJDX-UHFFFAOYSA-N 0.000 claims 1
- WXWJVMLNEFLGCC-UHFFFAOYSA-N 2-[3-methoxy-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-(trifluoromethyl)-1h-benzimidazole Chemical compound COC1=CC(C=2NC3=CC=C(C=C3N=2)C(F)(F)F)=CC=C1OCCCN1CCN(C)CC1 WXWJVMLNEFLGCC-UHFFFAOYSA-N 0.000 claims 1
- DOLJNIUPEWVSMY-UHFFFAOYSA-N 2-[3-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=CC=C3N=2)C=C1C DOLJNIUPEWVSMY-UHFFFAOYSA-N 0.000 claims 1
- KUBYFJXKFPBGHW-UHFFFAOYSA-N 2-[4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC1=CC=C(C=2NC3=CC=CC=C3N=2)C=C1 KUBYFJXKFPBGHW-UHFFFAOYSA-N 0.000 claims 1
- HIOACXJIFNRHFT-UHFFFAOYSA-N 4,5-dimethyl-2-[3-[4-(1-methylpiperidin-4-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCCOC1=CC=CC(C=2NC3=C(C)C(C)=CC=C3N=2)=C1 HIOACXJIFNRHFT-UHFFFAOYSA-N 0.000 claims 1
- XYCZNRPVEIXUGZ-UHFFFAOYSA-N 4,5-dimethyl-2-[3-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C)C(C)=C3N=2)C=C1C XYCZNRPVEIXUGZ-UHFFFAOYSA-N 0.000 claims 1
- CSEXYSDCKNILSQ-UHFFFAOYSA-N 4,6-dimethyl-2-[2-methyl-3-[4-(1-methylpiperidin-4-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCCOC1=CC=CC(C=2NC3=C(C)C=C(C)C=C3N=2)=C1C CSEXYSDCKNILSQ-UHFFFAOYSA-N 0.000 claims 1
- ZMUYSFLEOVTVQU-UHFFFAOYSA-N 4,6-dimethyl-2-[3-[4-(4-methyl-1,4-diazepan-1-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCCOC1=CC=CC(C=2NC3=CC(C)=CC(C)=C3N=2)=C1 ZMUYSFLEOVTVQU-UHFFFAOYSA-N 0.000 claims 1
- DBKCSJUURDYQKR-UHFFFAOYSA-N 4-[3-(6-tert-butyl-1h-benzimidazol-2-yl)phenoxy]-1-(4-methylpiperazin-1-yl)butan-1-one Chemical compound C1CN(C)CCN1C(=O)CCCOC1=CC=CC(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)=C1 DBKCSJUURDYQKR-UHFFFAOYSA-N 0.000 claims 1
- HEOOSKRYIMADSF-UHFFFAOYSA-N 4-[3-[4-(6-chloro-4-methyl-1h-benzimidazol-2-yl)-3-methylphenoxy]propyl]-1,4-diazepan-5-one Chemical compound C=1C=C(C=2NC3=CC(Cl)=CC(C)=C3N=2)C(C)=CC=1OCCCN1CCNCCC1=O HEOOSKRYIMADSF-UHFFFAOYSA-N 0.000 claims 1
- PXCXUOSJIMFZQQ-UHFFFAOYSA-N 4-[3-[4-(6-tert-butyl-1h-benzimidazol-2-yl)-3-methylphenoxy]propyl]-1-methyl-1,4-diazepan-5-one Chemical compound O=C1CCN(C)CCN1CCCOC(C=C1C)=CC=C1C1=NC2=CC(C(C)(C)C)=CC=C2N1 PXCXUOSJIMFZQQ-UHFFFAOYSA-N 0.000 claims 1
- LKAOLMAQJVBSHY-UHFFFAOYSA-N 4-chloro-2-[2-methyl-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1C)=CC=C1C1=NC2=C(Cl)C=CC=C2N1 LKAOLMAQJVBSHY-UHFFFAOYSA-N 0.000 claims 1
- RNBYJCBTCUPEML-UHFFFAOYSA-N 4-methyl-2-[3-[4-(1-methylpiperidin-4-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCCOC1=CC=CC(C=2NC3=C(C)C=CC=C3N=2)=C1 RNBYJCBTCUPEML-UHFFFAOYSA-N 0.000 claims 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 1
- NBYUHYMOOAWKJK-UHFFFAOYSA-N 5,6-dichloro-2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC(Cl)=C(Cl)C=C2N1 NBYUHYMOOAWKJK-UHFFFAOYSA-N 0.000 claims 1
- HUVLLIJCEAKWNB-UHFFFAOYSA-N 5,6-dichloro-2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC(Cl)=C(Cl)C=C3N=2)C=C1Cl HUVLLIJCEAKWNB-UHFFFAOYSA-N 0.000 claims 1
- YVBUIDRPKJTUJO-UHFFFAOYSA-N 5,6-difluoro-2-[3-fluoro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC(F)=C(F)C=C3N=2)C=C1F YVBUIDRPKJTUJO-UHFFFAOYSA-N 0.000 claims 1
- JYUNHIWFSACXRN-UHFFFAOYSA-N 5,6-dimethyl-2-[3-[4-(4-methylpiperazin-1-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCCOC1=CC=CC(C=2NC3=CC(C)=C(C)C=C3N=2)=C1 JYUNHIWFSACXRN-UHFFFAOYSA-N 0.000 claims 1
- DPLDJYIQOXPYEU-UHFFFAOYSA-N 5-chloro-2-[2-chloro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-6-fluoro-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC(Cl)=C(F)C=C2N1 DPLDJYIQOXPYEU-UHFFFAOYSA-N 0.000 claims 1
- DIUDUBNJSDXXFL-UHFFFAOYSA-N 5-chloro-2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-fluoro-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC(Cl)=C(F)C=C2N1 DIUDUBNJSDXXFL-UHFFFAOYSA-N 0.000 claims 1
- RCFCAROGHBIRJE-UHFFFAOYSA-N 5-chloro-2-[3-chloro-4-(3-piperazin-1-ylpropoxy)phenyl]-6-fluoro-1h-benzimidazole Chemical compound N=1C=2C=C(Cl)C(F)=CC=2NC=1C(C=C1Cl)=CC=C1OCCCN1CCNCC1 RCFCAROGHBIRJE-UHFFFAOYSA-N 0.000 claims 1
- FSUQVEFSMOUIAJ-UHFFFAOYSA-N 5-chloro-2-[3-chloro-4-[3-(4-methyl-1,4-diazepan-1-yl)propoxy]phenyl]-6-methyl-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCOC1=CC=C(C=2NC3=CC(C)=C(Cl)C=C3N=2)C=C1Cl FSUQVEFSMOUIAJ-UHFFFAOYSA-N 0.000 claims 1
- NNZBUWXJQQPPMT-UHFFFAOYSA-N 5-chloro-2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-fluoro-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC(F)=C(Cl)C=C3N=2)C=C1Cl NNZBUWXJQQPPMT-UHFFFAOYSA-N 0.000 claims 1
- NJEDSTVFVCYPMY-UHFFFAOYSA-N 5-chloro-2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-6-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC(C)=C(Cl)C=C3N=2)C=C1Cl NJEDSTVFVCYPMY-UHFFFAOYSA-N 0.000 claims 1
- DMLVEFMJJRWHCV-UHFFFAOYSA-N 5-chloro-6-fluoro-2-[3-fluoro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC(F)=C(Cl)C=C3N=2)C=C1F DMLVEFMJJRWHCV-UHFFFAOYSA-N 0.000 claims 1
- FWEZEGUGSRPQIY-UHFFFAOYSA-N 5-chloro-6-fluoro-2-[3-methoxy-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound COC1=CC(C=2NC3=CC(F)=C(Cl)C=C3N=2)=CC=C1OCCCN1CCN(C)CC1 FWEZEGUGSRPQIY-UHFFFAOYSA-N 0.000 claims 1
- ZGXXUVQKCZHGKT-UHFFFAOYSA-N 5-chloro-6-fluoro-2-[3-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC(F)=C(Cl)C=C3N=2)C=C1C ZGXXUVQKCZHGKT-UHFFFAOYSA-N 0.000 claims 1
- NNVQDEHLJNCUEI-UHFFFAOYSA-N 5-chloro-6-fluoro-2-[4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC1=CC=C(C=2NC3=CC(F)=C(Cl)C=C3N=2)C=C1 NNVQDEHLJNCUEI-UHFFFAOYSA-N 0.000 claims 1
- KDIDGPLTQLGXOK-UHFFFAOYSA-N 5-chloro-6-methyl-2-[3-[4-(4-methylpiperazin-1-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCCOC1=CC=CC(C=2NC3=CC(C)=C(Cl)C=C3N=2)=C1 KDIDGPLTQLGXOK-UHFFFAOYSA-N 0.000 claims 1
- LZKQGYGTXQJJDB-UHFFFAOYSA-N 5-chloro-6-methyl-2-[3-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC(C)=C(Cl)C=C3N=2)C=C1C LZKQGYGTXQJJDB-UHFFFAOYSA-N 0.000 claims 1
- AOYMZRROGAGWJJ-UHFFFAOYSA-N 5-chloro-6-methyl-2-[4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC1=CC=C(C=2NC3=CC(C)=C(Cl)C=C3N=2)C=C1 AOYMZRROGAGWJJ-UHFFFAOYSA-N 0.000 claims 1
- GXDGRCWNMCLOJO-UHFFFAOYSA-N 5-fluoro-4-methyl-2-[2-methyl-3-[4-(1-methylpiperidin-4-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCCOC1=CC=CC(C=2NC3=C(C)C(F)=CC=C3N=2)=C1C GXDGRCWNMCLOJO-UHFFFAOYSA-N 0.000 claims 1
- QLUAMGIZZNQTQA-UHFFFAOYSA-N 5-fluoro-4-methyl-2-[2-methyl-4-(3-piperidin-4-ylpropoxy)phenyl]-1h-benzimidazole Chemical compound C=1C=C(C=2NC3=CC=C(F)C(C)=C3N=2)C(C)=CC=1OCCCC1CCNCC1 QLUAMGIZZNQTQA-UHFFFAOYSA-N 0.000 claims 1
- VEHSXHVRSMGSIF-UHFFFAOYSA-N 5-fluoro-4-methyl-2-[2-methyl-4-[3-(1-methyl-3,6-dihydro-2h-pyridin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1N(C)CCC(CCCOC=2C=C(C)C(C=3NC4=CC=C(F)C(C)=C4N=3)=CC=2)=C1 VEHSXHVRSMGSIF-UHFFFAOYSA-N 0.000 claims 1
- JESCQINQDIAWHZ-UHFFFAOYSA-N 5-fluoro-4-methyl-2-[3-[3-(1-methylpiperidin-4-yl)oxypropoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1OCCCOC1=CC=CC(C=2NC3=C(C)C(F)=CC=C3N=2)=C1 JESCQINQDIAWHZ-UHFFFAOYSA-N 0.000 claims 1
- WLWJNOVUEPCFDS-UHFFFAOYSA-N 5-fluoro-4-methyl-2-[3-[4-(1-methylpiperidin-4-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCCOC1=CC=CC(C=2NC3=C(C)C(F)=CC=C3N=2)=C1 WLWJNOVUEPCFDS-UHFFFAOYSA-N 0.000 claims 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims 1
- WWIVPRUACCPFGN-UHFFFAOYSA-N 6-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-5h-[1,3]dioxolo[4,5-f]benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C(NC1=C2)=NC1=CC1=C2OCO1 WWIVPRUACCPFGN-UHFFFAOYSA-N 0.000 claims 1
- WEOCYBVTWOAPAM-UHFFFAOYSA-N 6-chloro-2-[2-chloro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=C(Cl)C=C2N1 WEOCYBVTWOAPAM-UHFFFAOYSA-N 0.000 claims 1
- YQMUHMFTPXJURR-UHFFFAOYSA-N 6-chloro-2-[2-chloro-4-[3-(4-methyl-1,4-diazepan-1-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=C(Cl)C=C2N1 YQMUHMFTPXJURR-UHFFFAOYSA-N 0.000 claims 1
- CXUANEOALAERQK-UHFFFAOYSA-N 6-chloro-2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=C(C)C=C(Cl)C=C2N1 CXUANEOALAERQK-UHFFFAOYSA-N 0.000 claims 1
- OFGGYRJGDHYJRQ-UHFFFAOYSA-N 6-chloro-2-[2-fluoro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1F)=CC=C1C1=NC2=C(C)C=C(Cl)C=C2N1 OFGGYRJGDHYJRQ-UHFFFAOYSA-N 0.000 claims 1
- VJLIUUYWNHAPBA-UHFFFAOYSA-N 6-chloro-2-[3-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(Cl)C=C3N=2)C=C1Cl VJLIUUYWNHAPBA-UHFFFAOYSA-N 0.000 claims 1
- SSNBYUQQKUOJNO-UHFFFAOYSA-N 6-chloro-2-[3-fluoro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(Cl)C=C3N=2)C=C1F SSNBYUQQKUOJNO-UHFFFAOYSA-N 0.000 claims 1
- PHEUJPDGUFJHEP-UHFFFAOYSA-N 6-chloro-2-[3-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(Cl)C=C3N=2)C=C1C PHEUJPDGUFJHEP-UHFFFAOYSA-N 0.000 claims 1
- NMXYLNCOHDRLNY-UHFFFAOYSA-N 6-chloro-2-[4-[3-(1-ethylpiperidin-4-yl)propoxy]-2-methylphenyl]-4-methyl-1h-benzimidazole Chemical compound C1CN(CC)CCC1CCCOC(C=C1C)=CC=C1C1=NC2=C(C)C=C(Cl)C=C2N1 NMXYLNCOHDRLNY-UHFFFAOYSA-N 0.000 claims 1
- KZRNMMIGSALIGC-UHFFFAOYSA-N 6-chloro-2-[4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC1=CC=C(C=2NC3=CC=C(Cl)C=C3N=2)C=C1 KZRNMMIGSALIGC-UHFFFAOYSA-N 0.000 claims 1
- XWPRDTKOKZWAJZ-UHFFFAOYSA-N 6-chloro-2-[4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(Cl)C=C3N=2)C=C1 XWPRDTKOKZWAJZ-UHFFFAOYSA-N 0.000 claims 1
- NDTYHHPIPMLFPJ-UHFFFAOYSA-N 6-chloro-4-methyl-2-[2-methyl-3-[4-(1-methylpiperidin-4-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCCOC1=CC=CC(C=2NC3=C(C)C=C(Cl)C=C3N=2)=C1C NDTYHHPIPMLFPJ-UHFFFAOYSA-N 0.000 claims 1
- RQRVIEWOHJNMFY-UHFFFAOYSA-N 6-chloro-4-methyl-2-[2-methyl-4-(3-piperidin-4-ylpropoxy)phenyl]-1h-benzimidazole Chemical compound C=1C=C(C=2NC3=CC(Cl)=CC(C)=C3N=2)C(C)=CC=1OCCCC1CCNCC1 RQRVIEWOHJNMFY-UHFFFAOYSA-N 0.000 claims 1
- XTGKURCRJIMIFI-UHFFFAOYSA-N 6-chloro-4-methyl-2-[2-methyl-4-[2-(1-methylpiperidin-4-yl)oxyethoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1OCCOC(C=C1C)=CC=C1C1=NC2=C(C)C=C(Cl)C=C2N1 XTGKURCRJIMIFI-UHFFFAOYSA-N 0.000 claims 1
- XQKWWEQHOPMFCD-UHFFFAOYSA-N 6-chloro-4-methyl-2-[2-methyl-4-[3-(1-methyl-3,6-dihydro-2h-pyridin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1N(C)CCC(CCCOC=2C=C(C)C(C=3NC4=CC(Cl)=CC(C)=C4N=3)=CC=2)=C1 XQKWWEQHOPMFCD-UHFFFAOYSA-N 0.000 claims 1
- SYOUDKBGICCOKX-UHFFFAOYSA-N 6-chloro-4-methyl-2-[2-methyl-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1C)=CC=C1C1=NC2=C(C)C=C(Cl)C=C2N1 SYOUDKBGICCOKX-UHFFFAOYSA-N 0.000 claims 1
- JXOFHZYRBASADB-UHFFFAOYSA-N 6-chloro-4-methyl-2-[3-[4-(1-methylpiperidin-4-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCCOC1=CC=CC(C=2NC3=C(C)C=C(Cl)C=C3N=2)=C1 JXOFHZYRBASADB-UHFFFAOYSA-N 0.000 claims 1
- WUGFTKIUHCZRCG-UHFFFAOYSA-N 6-fluoro-2-[2-methyl-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC(C=C1C)=CC=C1C1=NC2=CC(F)=CC=C2N1 WUGFTKIUHCZRCG-UHFFFAOYSA-N 0.000 claims 1
- FVLLXPGGVGVZRO-UHFFFAOYSA-N 6-methyl-2-[3-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C)C=C3N=2)C=C1C FVLLXPGGVGVZRO-UHFFFAOYSA-N 0.000 claims 1
- XSBCRFLXKSKNNQ-UHFFFAOYSA-N 6-methyl-2-[4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC1=CC=C(C=2NC3=CC=C(C)C=C3N=2)C=C1 XSBCRFLXKSKNNQ-UHFFFAOYSA-N 0.000 claims 1
- QNONLEQLMHGXNJ-UHFFFAOYSA-N 6-methyl-2-[4-[3-(4-methylpiperazin-1-yl)propoxy]naphthalen-1-yl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C1=CC=CC=C11)=CC=C1C1=NC2=CC(C)=CC=C2N1 QNONLEQLMHGXNJ-UHFFFAOYSA-N 0.000 claims 1
- ZPKHJXYJHFUOGM-UHFFFAOYSA-N 6-tert-butyl-2-[2-chloro-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC(C=C1Cl)=CC=C1C1=NC2=CC(C(C)(C)C)=CC=C2N1 ZPKHJXYJHFUOGM-UHFFFAOYSA-N 0.000 claims 1
- YQYKAUPZOMTZKZ-UHFFFAOYSA-N 6-tert-butyl-2-[3,5-dibromo-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=C(Br)C=C(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)C=C1Br YQYKAUPZOMTZKZ-UHFFFAOYSA-N 0.000 claims 1
- HZBLUKOLSHDOPE-UHFFFAOYSA-N 6-tert-butyl-2-[3-[4-(4-methyl-1,4-diazepan-1-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCCOC1=CC=CC(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)=C1 HZBLUKOLSHDOPE-UHFFFAOYSA-N 0.000 claims 1
- PYJSQDSYGDZKJI-UHFFFAOYSA-N 6-tert-butyl-2-[3-[4-(4-methylpiperazin-1-yl)butoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCCOC1=CC=CC(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)=C1 PYJSQDSYGDZKJI-UHFFFAOYSA-N 0.000 claims 1
- LMRCJLGEQACCRK-UHFFFAOYSA-N 6-tert-butyl-2-[3-chloro-4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC1=CC=C(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)C=C1Cl LMRCJLGEQACCRK-UHFFFAOYSA-N 0.000 claims 1
- LNGZQOILOUVGME-UHFFFAOYSA-N 6-tert-butyl-2-[3-chloro-4-[3-(4-methyl-1,4-diazepan-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCCN1CCCOC1=CC=C(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)C=C1Cl LNGZQOILOUVGME-UHFFFAOYSA-N 0.000 claims 1
- BUXJCSKEQCGFQR-UHFFFAOYSA-N 6-tert-butyl-2-[3-methyl-4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCN1CCCOC1=CC=C(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)C=C1C BUXJCSKEQCGFQR-UHFFFAOYSA-N 0.000 claims 1
- AHMUQXNADOPGII-UHFFFAOYSA-N 6-tert-butyl-2-[4-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]-1h-benzimidazole Chemical compound C1CN(C)CCC1CCCOC1=CC=C(C=2NC3=CC=C(C=C3N=2)C(C)(C)C)C=C1 AHMUQXNADOPGII-UHFFFAOYSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- KGBBISFIHACNGF-UHFFFAOYSA-N [2-(5-fluoro-4-methyl-1h-benzimidazol-2-yl)-5-[3-(1-methylpiperidin-4-yl)propoxy]phenyl]methanol Chemical compound C1CN(C)CCC1CCCOC(C=C1CO)=CC=C1C1=NC2=C(C)C(F)=CC=C2N1 KGBBISFIHACNGF-UHFFFAOYSA-N 0.000 claims 1
- LBYSSZRTKTVGLK-UHFFFAOYSA-N [2-[3-[4-(4-methylpiperazin-1-yl)butoxy]phenyl]-3h-benzimidazol-5-yl]-phenylmethanone Chemical compound C1CN(C)CCN1CCCCOC1=CC=CC(C=2NC3=CC=C(C=C3N=2)C(=O)C=2C=CC=CC=2)=C1 LBYSSZRTKTVGLK-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- HYVDTQLGJQUZBU-UHFFFAOYSA-N n-[2-[3-chloro-4-(4-methyl-1h-benzimidazol-2-yl)phenoxy]ethyl]-n,1-dimethylpiperidin-4-amine Chemical compound C=1C=C(C=2NC3=CC=CC(C)=C3N=2)C(Cl)=CC=1OCCN(C)C1CCN(C)CC1 HYVDTQLGJQUZBU-UHFFFAOYSA-N 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50723103P | 2003-09-30 | 2003-09-30 | |
| US60/507,231 | 2003-09-30 | ||
| PCT/US2004/031855 WO2005044807A2 (en) | 2003-09-30 | 2004-09-29 | Benzoimidazole compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007507511A JP2007507511A (ja) | 2007-03-29 |
| JP2007507511A5 true JP2007507511A5 (enExample) | 2008-01-24 |
| JP4767857B2 JP4767857B2 (ja) | 2011-09-07 |
Family
ID=43348994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006534029A Expired - Fee Related JP4767857B2 (ja) | 2003-09-30 | 2004-09-29 | ベンゾイミダゾール化合物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060127404A1 (enExample) |
| EP (1) | EP1687452A4 (enExample) |
| JP (1) | JP4767857B2 (enExample) |
| CN (1) | CN1890383A (enExample) |
| AU (1) | AU2004316266A1 (enExample) |
| WO (1) | WO2005081687A2 (enExample) |
Families Citing this family (108)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100034819A1 (en) * | 2006-03-31 | 2010-02-11 | Centocor Inc. | Human epo mimetic hinge core mimetibodies, compositions, methods and uses for preventing or treating glucose intolerance related conditions on renal disease associated anemia |
| CA2663536A1 (en) * | 2006-10-24 | 2008-05-02 | Trubion Pharmaceuticals, Inc. | Materials and methods for improved immunoglycoproteins |
| US7846434B2 (en) | 2006-10-24 | 2010-12-07 | Trubion Pharmaceuticals, Inc. | Materials and methods for improved immunoglycoproteins |
| US8278415B2 (en) | 2006-12-21 | 2012-10-02 | Centocor, Inc. | Dimeric high affinity EGFR constructs and uses thereof |
| WO2008079982A2 (en) | 2006-12-21 | 2008-07-03 | Centocor, Inc. | Liposome composition for targeting egfr receptor |
| WO2008079973A2 (en) | 2006-12-21 | 2008-07-03 | Centocor, Inc. | Egfr binding peptides and uses thereof |
| AU2008303928A1 (en) * | 2007-09-11 | 2009-04-02 | Mondobiotech Laboratories Ag | Use of NF-KAPPAB inhibitor SN50 and optionally angiotensin III as therapeutic agents in the treatment of EG HBV infection |
| AU2008304111B2 (en) | 2007-09-27 | 2014-04-24 | Amgen Inc. | Pharmaceutical formulations |
| US8796206B2 (en) | 2007-11-15 | 2014-08-05 | Amgen Inc. | Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration |
| EP2803675A3 (en) | 2008-01-25 | 2014-12-24 | Amgen, Inc | Ferroportin antibodies and methods of use |
| WO2009139822A1 (en) | 2008-05-01 | 2009-11-19 | Amgen Inc. | Anti-hepcidin antibodies and methods of use |
| EA020090B1 (ru) * | 2008-06-30 | 2014-08-29 | Янссен Фармацевтика Нв | Способ получения и рекристаллизации кристаллического гемитартрата бензоимидазол-2-илпиримидинового производного |
| CA2742871C (en) | 2008-11-13 | 2018-10-23 | Herb Lin | Methods and compositions for regulating iron homeostasis by modulation of bmp-6 |
| MX2011008936A (es) * | 2009-02-24 | 2011-09-21 | Alexion Pharma Inc | Anticuerpos que contienen peptidos terapeuticos mimeticos de tpo/epo. |
| US20100291160A1 (en) * | 2009-05-13 | 2010-11-18 | Carver David R | Pharmaceutical system for trans-membrane delivery |
| RU2636614C2 (ru) * | 2009-05-19 | 2017-11-24 | Вивия Байотек С.Л. | Способы персонализированного медицинского тестирования ex vivo на гематологические новообразования |
| IT1395137B1 (it) * | 2009-08-05 | 2012-09-05 | Spider Biotech S R L | Nuovi peptidi antipatogeni |
| US9662271B2 (en) | 2009-10-23 | 2017-05-30 | Amgen Inc. | Vial adapter and system |
| CN102741403B (zh) | 2009-11-17 | 2016-04-13 | 詹森生物科技公司 | 二硫键连接的二聚体蛋白质在丝状噬菌体上的展示 |
| CN104531734A (zh) | 2009-11-17 | 2015-04-22 | 詹森生物科技公司 | 改善的细菌膜蛋白分泌 |
| US8895700B2 (en) | 2010-02-18 | 2014-11-25 | Janssen Biotech, Inc. | Monkey homolog of human interferon omega |
| JP5908888B2 (ja) | 2010-04-16 | 2016-04-26 | ヤンセン バイオテツク，インコーポレーテツド | 改変された植物のシステインプロテアーゼ及びその使用 |
| ES2545411T5 (es) | 2010-06-07 | 2024-04-05 | Amgen Inc | Dispositivo de administración de fármaco |
| EP2621950A4 (en) | 2010-09-27 | 2015-09-02 | Janssen Biotech Inc | ANTIBODIES FOR BINDING HUMAN COLLAGEN II |
| EP2447263A1 (en) * | 2010-09-27 | 2012-05-02 | Bioprojet | Benzazole derivatives as histamine H4 receptor ligands |
| WO2012135315A1 (en) | 2011-03-31 | 2012-10-04 | Amgen Inc. | Vial adapter and system |
| LT2699293T (lt) | 2011-04-20 | 2019-04-25 | Amgen Inc. | Automatinio purškimo prietaisas |
| EP3045187B1 (en) | 2011-10-14 | 2019-04-10 | Amgen Inc. | Injector and method of assembly |
| JP2015535464A (ja) | 2012-11-21 | 2015-12-14 | アムジエン・インコーポレーテツド | 薬剤送達装置 |
| TWI592183B (zh) | 2013-03-15 | 2017-07-21 | 安美基公司 | 本體輪廓可調適之自動注射器裝置 |
| CA2904357C (en) | 2013-03-15 | 2020-09-22 | Intrinsic Lifesciences Llc | Anti-hepcidin antibodies and uses thereof |
| US10492990B2 (en) | 2013-03-15 | 2019-12-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
| US10092703B2 (en) | 2013-03-15 | 2018-10-09 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
| ES2853748T3 (es) | 2013-03-22 | 2021-09-17 | Amgen Inc | Inyector y método de montaje |
| MX2016005315A (es) | 2013-10-24 | 2016-08-11 | Amgen Inc | Sistema de administracion de farmacos con control sensible a la temperatura. |
| EP3060275B1 (en) | 2013-10-24 | 2019-07-03 | Amgen Inc. | Injector and method of assembly |
| WO2015119906A1 (en) | 2014-02-05 | 2015-08-13 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
| SG11201609219QA (en) | 2014-05-07 | 2016-12-29 | Amgen Inc | Autoinjector with shock reducing elements |
| US20170103186A1 (en) | 2014-06-03 | 2017-04-13 | Amgen Inc. | Systems and methods for supporting patient use of a drug delivery device |
| CA2961917A1 (en) | 2014-09-22 | 2016-03-31 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
| ES3056224T3 (en) | 2014-10-14 | 2026-02-19 | Amgen Inc | Drug injection device with visual and audible indicators |
| US10799630B2 (en) | 2014-12-19 | 2020-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
| EP3689394A1 (en) | 2014-12-19 | 2020-08-05 | Amgen Inc. | Drug delivery device with live button or user interface field |
| US10583245B2 (en) | 2015-02-17 | 2020-03-10 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
| ES2905870T3 (es) | 2015-02-27 | 2022-04-12 | Amgen Inc | Dispositivo de suministro de fármacos que tiene un mecanismo de protección de aguja con un umbral de resistencia ajustable al movimiento de la protección de aguja |
| WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
| JP7082568B2 (ja) | 2015-12-09 | 2022-06-08 | アムジエン・インコーポレーテツド | 信号伝達キャップ付き自動注射器 |
| WO2017120178A1 (en) | 2016-01-06 | 2017-07-13 | Amgen Inc. | Auto-injector with signaling electronics |
| WO2017160799A1 (en) | 2016-03-15 | 2017-09-21 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
| CN105713880A (zh) * | 2016-04-20 | 2016-06-29 | 广东艾时代生物科技有限责任公司 | 一种造血干细胞体外扩增培养的无血清培养基及其应用 |
| WO2017189089A1 (en) | 2016-04-29 | 2017-11-02 | Amgen Inc. | Drug delivery device with messaging label |
| US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
| MX2018013616A (es) | 2016-05-13 | 2019-02-21 | Amgen Inc | Montaje de cubierta protectora de vial. |
| WO2017200989A1 (en) | 2016-05-16 | 2017-11-23 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
| ES3066292T3 (en) | 2016-06-03 | 2026-05-12 | Amgen Inc | Impact testing apparatuses and methods for drug delivery devices |
| EP3478342B1 (en) | 2016-07-01 | 2025-03-12 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
| US20190328965A1 (en) | 2016-08-17 | 2019-10-31 | Amgen Inc. | Drug delivery device with placement detection |
| EP3532127B1 (en) | 2016-10-25 | 2026-04-08 | Amgen Inc. | On-body injector |
| WO2018136398A1 (en) | 2017-01-17 | 2018-07-26 | Amgen Inc. | Injection devices and related methods of use and assembly |
| AU2018220538B2 (en) | 2017-02-17 | 2023-12-14 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
| MX2019009755A (es) | 2017-02-17 | 2019-10-07 | Amgen Inc | Mecanismo de insercion para dispositivo de suministro de farmacos. |
| WO2018165143A1 (en) | 2017-03-06 | 2018-09-13 | Amgen Inc. | Drug delivery device with activation prevention feature |
| KR102627069B1 (ko) | 2017-03-07 | 2024-01-18 | 암겐 인코포레이티드 | 과압에 의한 바늘 삽입 |
| SG11201908062QA (en) | 2017-03-09 | 2019-09-27 | Amgen Inc | Insertion mechanism for drug delivery device |
| WO2018172219A1 (en) | 2017-03-20 | 2018-09-27 | F. Hoffmann-La Roche Ag | Method for in vitro glycoengineering of an erythropoiesis stimulating protein |
| MX2019011416A (es) | 2017-03-28 | 2019-11-01 | Amgen Inc | Sistema y metodo para conjunto de jeringa y vastago de embolo. |
| CA3066399A1 (en) | 2017-06-08 | 2018-12-13 | Amgen Inc. | Torque driven drug delivery device |
| AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
| MA49447A (fr) | 2017-06-22 | 2020-04-29 | Amgen Inc | Réduction des impacts/chocs d'activation d'un dispositif |
| JP7475860B2 (ja) | 2017-06-23 | 2024-04-30 | アムジエン・インコーポレーテツド | スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス |
| JP7408398B2 (ja) | 2017-07-14 | 2024-01-05 | アムジエン・インコーポレーテツド | 二重ねじりばねシステムを有する針挿入後退システム |
| JP7649105B2 (ja) | 2017-07-21 | 2025-03-19 | アムジエン・インコーポレーテツド | 薬物容器のためのガス透過性シーリング部材及び組立方法 |
| WO2019022951A1 (en) | 2017-07-25 | 2019-01-31 | Amgen Inc. | DRUG DELIVERY DEVICE WITH GEAR MODULE AND ASSEMBLY METHOD THEREOF |
| EP3658206A1 (en) | 2017-07-25 | 2020-06-03 | Amgen Inc. | Drug delivery device with container access system and related method of assembly |
| US12318593B2 (en) | 2017-08-09 | 2025-06-03 | Amgen Inc. | Hydraulic-pneumatic pressurized chamber drug delivery system |
| EP3668567B1 (en) | 2017-08-18 | 2026-02-18 | Amgen Inc. | Wearable injector with sterile adhesive patch |
| US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
| EP3691717B1 (en) | 2017-10-04 | 2023-02-08 | Amgen Inc. | Flow adapter for drug delivery device |
| EP4257164A3 (en) | 2017-10-06 | 2024-01-17 | Amgen Inc. | Drug delivery device with interlock assembly and related method of assembly |
| MA50348A (fr) | 2017-10-09 | 2020-08-19 | Amgen Inc | Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé |
| ES3069718T3 (en) | 2017-11-03 | 2026-06-10 | Amgen Inc | System and approaches for sterilizing a drug delivery device |
| MA50569A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Ensembles de remplissage-finition et procédés associés |
| CA3079197A1 (en) | 2017-11-06 | 2019-05-09 | Amgen Inc. | Drug delivery device with placement and flow sensing |
| IL319987A (en) | 2017-11-10 | 2025-06-01 | Amgen Inc | Plungers for drug delivery devices |
| JP7747438B2 (ja) | 2017-11-16 | 2025-10-01 | アムジエン・インコーポレーテツド | 失速及び終点検出を有するオートインジェクタ |
| AU2018368340B2 (en) | 2017-11-16 | 2024-03-07 | Amgen Inc. | Door latch mechanism for drug delivery device |
| CN108129561B (zh) * | 2017-12-06 | 2021-05-25 | 渤海大学 | 一种ace抑制肽 |
| US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
| US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
| CN112469454B (zh) | 2018-07-24 | 2024-01-26 | 安进公司 | 用于施用药物的输送装置 |
| CA3103682A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Delivery devices for administering drugs |
| WO2020023336A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
| US12303677B2 (en) | 2018-07-24 | 2025-05-20 | Amgen Inc. | Hybrid drug delivery devices with optional grip portion and related method of preparation |
| MA53320A (fr) | 2018-07-31 | 2021-11-03 | Amgen Inc | Ensemble de trajet de fluide pour dispositif d'administration de médicament |
| CA3106452A1 (en) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Interventional dosing systems and methods |
| US12042642B2 (en) | 2018-09-28 | 2024-07-23 | Amgen Inc. | Muscle wire escapement activation assembly for a drug delivery device |
| WO2020072577A1 (en) | 2018-10-02 | 2020-04-09 | Amgen Inc. | Injection systems for drug delivery with internal force transmission |
| JP7547325B2 (ja) | 2018-10-05 | 2024-09-09 | アムジエン・インコーポレーテツド | 投薬量インジケータを有する薬物送達デバイス |
| MA53913A (fr) | 2018-10-15 | 2022-01-19 | Amgen Inc | Procédé d'assemblage de plate-forme pour dispositif d'administration de médicament |
| JP7719714B2 (ja) | 2018-10-15 | 2025-08-06 | アムジエン・インコーポレーテツド | ダンピング機構を有する薬物送達装置 |
| MA54057A (fr) | 2018-11-01 | 2022-02-09 | Amgen Inc | Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament |
| TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
| WO2020091956A1 (en) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
| EP3958934B1 (en) | 2019-04-24 | 2025-04-09 | Amgen Inc. | Syringe sterilization verification assemblies and methods |
| US20220273887A1 (en) | 2019-08-23 | 2022-09-01 | Amgen Inc. | Drug delivery device with configurable needle shield engagement components and related methods |
| BR112023024278A2 (pt) | 2021-05-21 | 2024-01-30 | Amgen Inc | Método de otimizar uma receita de enchimento para um recipiente de fármacos |
| JP2025536587A (ja) | 2022-11-02 | 2025-11-07 | エフ． ホフマン－ラ ロシュ アーゲー | 糖タンパク質組成物を生産するための方法 |
| WO2026030152A1 (en) | 2024-07-29 | 2026-02-05 | Amgen Inc. | System and method for assessing transferability of a fill recipe |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69334275D1 (de) * | 1992-08-21 | 2009-05-20 | Univ Bruxelles | Immunoglobuline ohne Leichtkette |
| PE27997A1 (es) * | 1994-04-29 | 1997-09-20 | Lilly Co Eli | Antagonistas de receptores de taquicininas |
| US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| TR200101239T2 (tr) * | 1998-11-03 | 2001-11-21 | Basf Aktiengesellschaft | İkameli-2-fenilbenzimidazoller, üretimleri ve kullanımları |
| DE19920936A1 (de) * | 1999-05-07 | 2000-11-09 | Basf Ag | Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung |
| PT2857516T (pt) * | 2000-04-11 | 2017-08-28 | Genentech Inc | Anticorpos multivalentes e utilizações dos mesmos |
| EP1370589B1 (en) * | 2000-12-05 | 2006-03-15 | Alexion Pharmaceuticals, Inc. | Rationally designed antibodies |
| WO2002072548A2 (en) * | 2001-03-09 | 2002-09-19 | Ortho-Mcneil Pharmaceutical, Inc. | Heterocyclic compounds and their use as histamine h4 ligands. |
| WO2004002417A2 (en) * | 2002-06-28 | 2004-01-08 | Centocor, Inc. | Mammalian ch1 deleted mimetibodies, compositions, methods and uses |
| US7241733B2 (en) * | 2002-06-28 | 2007-07-10 | Centocor, Inc. | Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |
| EP1644416A4 (en) * | 2003-06-30 | 2007-08-29 | Centocor Inc | ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
-
2004
- 2004-09-29 US US10/953,613 patent/US20060127404A1/en not_active Abandoned
- 2004-09-29 CN CNA2004800353031A patent/CN1890383A/zh active Pending
- 2004-09-29 JP JP2006534029A patent/JP4767857B2/ja not_active Expired - Fee Related
- 2004-09-29 EP EP04821516A patent/EP1687452A4/en not_active Withdrawn
- 2004-09-29 WO PCT/US2004/031858 patent/WO2005081687A2/en not_active Ceased
- 2004-09-29 AU AU2004316266A patent/AU2004316266A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007534687A5 (enExample) | ||
| JP2018535999A5 (enExample) | ||
| JP2012515787A5 (enExample) | ||
| JP2014526501A5 (enExample) | ||
| JP2004518651A5 (enExample) | ||
| JP2009536196A5 (enExample) | ||
| JP2019537594A5 (enExample) | ||
| RU2018110770A (ru) | Ингибиторы mdm2 и их комбинации | |
| JP2001526211A5 (enExample) | ||
| JP2011504497A5 (enExample) | ||
| RU2008141509A (ru) | Mglur5 модуляторы 1 | |
| JP2020520357A5 (enExample) | ||
| JP2002540155A5 (enExample) | ||
| RU2009144191A (ru) | Имидазопиридиновые ингибиторы киназ | |
| RU2011105151A (ru) | Азольные соединения | |
| JP2003528810A5 (enExample) | ||
| JP2001526276A5 (enExample) | ||
| JP2003525872A5 (enExample) | ||
| JP2004520292A5 (enExample) | ||
| JP2004523535A5 (enExample) | ||
| JP2013545798A5 (enExample) | ||
| CA2534228A1 (en) | Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators | |
| JP2008520741A5 (enExample) | ||
| JP2011501735A5 (enExample) | ||
| JP2007523142A5 (enExample) |